Latest News and Press Releases
Want to stay updated on the latest news?
-
FRANKFURT, Germany and PRINCETON, N.J. and BANGALORE, India, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, today announced the launch of a new...
-
Rockville, Jan. 10, 2023 (GLOBE NEWSWIRE) -- According to a newly published research report by Fact.MR, a provider of market research and competitive intelligence, global consumption of chaga...
-
LOS ANGELES, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) , is proud to announce it has signed a Letter of Intent entering...
-
Wilmington, Delaware, United States, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - According to TMR study, the global sustainable packaging market was valued US$ 252.4 Bn in...
-
IRVINE, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”), a clinical-stage biopharmaceutical company focused on developing a proprietary botulinum toxin...
-
CLEVELAND, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Lincoln Electric Holdings, Inc. (the “Company”) (Nasdaq: LECO) today announced that the Company’s 2023 Annual Meeting of Shareholders will be held as a...
-
MONTREAL, Jan. 10, 2023 (GLOBE NEWSWIRE) -- PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (NASDAQ: PYR) (FRA: 8PY), a TSX30® and a Deloitte Technology Fast 50™ high-tech company...
-
SAN DIEGO and HEERLEN, The Netherlands, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Floré by Sun Genomics, the world’s only fully customized precision probiotic, announced today its partnership with health,...
-
Complete Phase 2 clinical trial enrollment in Epidermolysis Bullosa in 1Q 2023Progress preclinical research in glaucoma in preparation for human trialsAdvance research using rare cannabinoids in...
-
The Company is Already Outperforming Previous Revenue Numbers After Its Successful Renovation PHOENIX, AZ , Jan. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Today American Green (ERBB:OTC) is...